A-SPINE Asia Co., Ltd. (6758) fair value: what the stock is really worth
As of Sep 24, 2026: fair value of A-SPINE Asia Co., Ltd. TWD 19.03, price TWD 30.80, upside -38.2%, quality 70 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch A-SPINE Asia Co., Ltd. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 27.04 TWD – 46.49 TWD · fair‑value band 14.39 TWD – 23.79 TWD · the 30.80 TWD price screens above the 19.03 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow A-SPINE Asia Co. in your weekly email
Every Wednesday you see whether A-SPINE Asia Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka.
Show more
A-SPINE Asia Co., Ltd., a medical device company, engages in the research, development, manufacture, and marketing of spinal implants and instruments in Taiwan, China, the Philippines, Australia, New Zealand, Iran, Vietnam, Indonesia, Spain, Trinidad, and Sri Lanka. The company offers spinal fixation systems, such as cervical anterior fixation, and thoracic and lumbar fixation systems; interbody fixation systems, including ACDF cages, PLIF/TLIF cages, and ALIF cages; balloon kyphoplasty products; and vertebral body replacement products. It sells imported orthopedic medical devices. A-SPINE Asia Co., Ltd.was founded in 2001 and is based in New Taipei City, Taiwan.
Stock analysis
A-SPINE Asia Co., Ltd. (6758) currently trades at 30.80 TWD, while our model-based Fair Value estimate is 19.03 TWD, implying the stock looks roughly 61.8% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 30.37 TWD per share, and 6 of the 25 models we run sit above the 30.80 TWD price.
Bear case: the Dividend Discount group reads lowest at 13.31 TWD, and 19 of the 25 models stay below the price. Evidence for this calculation is low.
Scenario range: 14.39 TWD (bear) to 23.79 TWD (bull), the price of 30.80 TWD sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 70/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
A-SPINE Asia Co., Ltd. reported revenue of 449M TWD in FY2025 versus 310M TWD in FY2021, a compound +9.7%/yr. Reported net income was 15.1M TWD in FY2025, compounding −4.0%/yr from FY2021.
Key figures
Market cap 415M TWD (≈ $13.1M) · P/E ratio 27.7 · P/S ratio 0.93 · EPS (TTM) 1.11 TWD · Dividend yield 3.4% · Net margin 3.4% · Return on assets (EBIT) 2.6% · Free cash flow 28.2M TWD.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 14% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 5% fair-value upside, at −38%, 6758 screens richer than that median.
Fair Value models
Bear 14.39 TWDFair Value 19.03 TWDBull 23.79 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (0.8150 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.61/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+10.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.8%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.9%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.1%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−9.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year−13.0%
Dividend (yield on the price)3.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−13% vs −11%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.9% → 4%
2025 sits 80% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +6.9% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 365 stocks
Beats the industry median on 4/11 measures
Overall it trails its industry peers.
Valuation
Quality Score70 · Top 25%
Fair Value upside−38% · Below median
Profitability
Return on assets0% · Below median
Net margin (TTM)3% · Below median
Operating margin (TTM)0% · Below median
Growth and dividend
Revenue growth0% · Below median
Dividend yield (TTM)3.4% · Top 25%
Balance sheet
Debt / equity0.12× · Above median
Valuation Multiplesvs Medical Devices median · lower = cheaper
P/E (TTM)27.7× · Pricier than median
P/B0.05× · Cheapest 25%
P/FCF0.5× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 10
FUTURE (revenue growth)0· sector 31
PAST (return on equity)0· sector 7
HEALTH (low debt)94· sector 97
DIVIDEND (yield)68· sector 40
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "A-SPINE Asia Co., Ltd. Fair Value". https://www.fairvalue-calculator.com/stock/6758
Frequently asked questions
Is A-SPINE Asia Co., Ltd. (6758) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 19.03 TWD versus a price of 30.80 TWD, about −38% upside (overvalued).
What is the fair value of 6758?
Our model-based fair value for A-SPINE Asia Co., Ltd. is 19.03 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 30.80 TWD.
What is the quality score of 6758?
A-SPINE Asia Co., Ltd. has a Quality Score of 70/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for A-SPINE Asia Co., Ltd. (6758)?
Our model-based price target is the fair value of 19.03 TWD (as of Sep 24, 2026) from 25 valuation models. Cautious scenario 14.39 TWD, optimistic scenario 23.79 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the A-SPINE Asia Co., Ltd. stock forecast for 2026?
Our models put fair value at 19.03 TWD, about −38% upside versus a price of 30.80 TWD (overvalued). Cautious scenario 14.39 TWD, optimistic scenario 23.79 TWD. The calculation is refreshed regularly with new filings.
Does A-SPINE Asia Co., Ltd. pay a dividend?
A-SPINE Asia Co., Ltd. currently shows a dividend yield of about 3.42% relative to its recent price (as of Sep 24, 2026).
What growth is priced into A-SPINE Asia Co., Ltd. (6758)?
For today's price to be fair in a discounted-cash-flow model, A-SPINE Asia Co., Ltd. would have to grow free cash flow by +8.6 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.9 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 6758 use?
Our models discount A-SPINE Asia Co., Ltd. at 10.3 %: a base by market capitalisation (nano), country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For A-SPINE Asia Co., Ltd. that is +8.6 % per year a year over ten years, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has A-SPINE Asia Co., Ltd. (6758) delivered so far?
Over the past 5 years revenue at A-SPINE Asia Co., Ltd. grew +3.9 % a year. The price currently implies +8.6 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of A-SPINE Asia Co., Ltd. (6758) growing?
The median revenue growth in the sector is +0.0 % a year. That is the yardstick for the growth priced into A-SPINE Asia Co., Ltd. (+8.6 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of A-SPINE Asia Co., Ltd. (6758)?
The free-cash-flow yield on the price is 6.79 %: that much free cash flow A-SPINE Asia Co., Ltd. produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of A-SPINE Asia Co., Ltd. (6758)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For A-SPINE Asia Co., Ltd. it is 19.03 TWD per share (as of Sep 24, 2026), against a price of 30.80 TWD. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is A-SPINE Asia Co., Ltd. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 6758 trades above its calculated fair value: price 30.80 TWD, fair value 19.03 TWD, a gap of about −38% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6758?
No. The price is what the market pays today (30.80 TWD); the fair value is what the company's own numbers justify (19.03 TWD). For A-SPINE Asia Co., Ltd. the two are 11.77 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is A-SPINE Asia Co., Ltd. worth?
The market values A-SPINE Asia Co., Ltd. at about 415M TWD (market capitalisation, as of Sep 24, 2026). Per share that is 30.80 TWD; our models calculate a fair value of 19.03 TWD per share.
What do the bullish and bearish scenarios say about 6758?
Our models span a range for A-SPINE Asia Co., Ltd.: cautious scenario 14.39 TWD, base 19.03 TWD, optimistic 23.79 TWD per share (as of Sep 24, 2026, price 30.80 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6758?
A-SPINE Asia Co., Ltd. trades at a price-to-earnings ratio of 27.7 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 19.03 TWD is built from several models across several years. Other multiples: P/B 0.1.
How solid is the balance sheet of A-SPINE Asia Co., Ltd. (6758)?
Balance-sheet figures for A-SPINE Asia Co., Ltd. (as of Sep 24, 2026): debt of 0.12 per unit of equity. They feed the Quality Score of 70/100, which measures business quality independently of the share price.
How far is 6758 from its 52-week high?
A-SPINE Asia Co., Ltd. trades at 30.80 TWD, about 26% below its 52-week high of 41.53 TWD and 14% above the low of 27.04 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 19.03 TWD is for.
Which stocks are comparable to A-SPINE Asia Co., Ltd.?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is A-SPINE Asia Co., Ltd. stock attractive at the current price?
The data as of Sep 24, 2026: price 30.80 TWD, calculated fair value 19.03 TWD (−38%), Quality Score 70/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6758 calculated?
We run A-SPINE Asia Co., Ltd. through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 19.03 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. A-SPINE Asia Co., Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of A-SPINE Asia Co., Ltd. (6758)?
The closing price on Sep 24, 2026 was 30.80 TWD. Our model-based fair value is 19.03 TWD, about −38% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with A-SPINE Asia Co., Ltd. right now?
A high-quality business (quality 70/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (23.79 TWD). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of A-SPINE Asia Co., Ltd.
How large is the market capitalisation of A-SPINE Asia Co., Ltd. (6758)?
The market capitalisation of A-SPINE Asia Co., Ltd. is 415M TWD (≈ $13.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of A-SPINE Asia Co., Ltd. (6758)?
The price-to-sales ratio of A-SPINE Asia Co., Ltd. is 0.93 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of A-SPINE Asia Co., Ltd. (6758)?
Earnings per share at A-SPINE Asia Co., Ltd. are 1.11 TWD (price ÷ EPS = P/E 27.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of A-SPINE Asia Co., Ltd. (6758)?
The dividend yield of A-SPINE Asia Co., Ltd. is 3.4% (payout 94.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of A-SPINE Asia Co., Ltd. (6758)?
The net margin of A-SPINE Asia Co., Ltd. is 3.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of A-SPINE Asia Co., Ltd. (6758)?
On an EBIT basis the return on assets of A-SPINE Asia Co., Ltd. is 2.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net debt does A-SPINE Asia Co., Ltd. (6758) carry?
The net debt of A-SPINE Asia Co., Ltd. is 71.8M TWD (fiscal year 2025, ≈ 2.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch A-SPINE Asia Co., Ltd. in the live analysis
One click puts A-SPINE Asia Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
